Table 2 Comparison of clinical data among clustered groups
TP53 mutation group | Without TP53 mutation group | CNV group | p† | |
|---|---|---|---|---|
(n = 15) | (n = 12) | (n = 7) | ||
Age, mean ± SD, years | 68.3 ± 10.2 | 74.3 ± 9.2 | 76.1 ± 10.9 | 0.100 |
Sex, male, n (%) | 4 (26.7) | 2 (16.7) | 3 (42.9) | 0.160 |
Gallstones, n (%) | 5 (33.3) | 6 (50) | 4 (57.1) | 0.510 |
Smoking, n (%)a | 1 (10) | 2 (16.7) | 2 (28.6) | 0.610 |
PBM, n (%)a | 6 (60) | 2 (20) | 0 | 0.027 |
Histological type | 0.130 | |||
pap, n (%) | 6 (40) | 5 (41.7) | 0 | |
tub1, n (%) | 7 (46.7) | 4 (33.3) | 2 (28.6) | |
tub2, n (%) | 2 (13.3) | 2 (16.7) | 3 (42.9) | |
poor, n (%) | 0 | 1 (8.3) | 2 | |
T factor | 0.410 | |||
T1, n (%) | 4 (26.7) | 3 (25) | 0 | |
T2, n (%) | 9 (60) | 7 (58.3) | 4 (57.1) | |
T3, n (%) | 2 (13.3) | 2 (16.7) | 3 (42.9) | |
Lymph node metastasis, n (%) | 5 (33.3) | 2 (16.7) | 3 (42.9) | 0.440 |
Number of actionable genes, median (range) | 1 (0–1) | 0 (0–2) | 4 (3–5) | < 0.01 |